Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2008 3
2010 4
2011 7
2012 15
2013 28
2014 34
2015 30
2016 45
2017 64
2018 83
2019 57
2020 83
2021 88
2022 97
2023 31
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28838092

588 results

Results by year

Filters applied: . Clear all
Page 1
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW. Head SJ, et al. Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21. Eur Heart J. 2014. PMID: 24849105 Clinical Trial.
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, Dawkins KD, Mack MJ; SYNTAX Investigators. Kappetein AP, et al. Eur J Cardiothorac Surg. 2013 May;43(5):1006-13. doi: 10.1093/ejcts/ezt017. Epub 2013 Feb 14. Eur J Cardiothorac Surg. 2013. PMID: 23413014 Clinical Trial.
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Palmerini T, Serruys P, Kappetein AP, Genereux P, Riva DD, Reggiani LB, Christiansen EH, Holm NR, Thuesen L, Makikallio T, Morice MC, Ahn JM, Park SJ, Thiele H, Boudriot E, Sabatino M, Romanello M, Biondi-Zoccai G, Cavalcante R, Sabik JF, Stone GW. Palmerini T, et al. Am Heart J. 2017 Aug;190:54-63. doi: 10.1016/j.ahj.2017.05.005. Epub 2017 May 18. Am Heart J. 2017. PMID: 28760214 Review.
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients.
Alam M, Huang HD, Shahzad SA, Kar B, Virani SS, Rogers PA, Paniagua D, Bozkurt B, Palacios I, Kleiman NS, Jneid H. Alam M, et al. Circ J. 2013;77(2):372-82. doi: 10.1253/circj.cj-12-0747. Epub 2012 Oct 31. Circ J. 2013. PMID: 23123552 Free article. Review.
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
Garg A, Rao SV, Agrawal S, Theodoropoulos K, Mennuni M, Sharma A, Garg L, Ferrante G, Meelu OA, Sargsyan D, Reimers B, Cohen M, Kostis JB, Stefanini GG. Garg A, et al. Am J Cardiol. 2017 Jun 15;119(12):1942-1948. doi: 10.1016/j.amjcard.2017.03.019. Epub 2017 Mar 29. Am J Cardiol. 2017. PMID: 28433215 Review.
588 results